Treatment of schizophrenia in subjects with substance use disorders

G. Rubio Valladolid, M. Casas Brugué

    Research output: Contribution to journalReview articleResearchpeer-review

    13 Citations (Scopus)


    Background: Schizophrenic patients have a high comorbidity with substance use disorders. However, there are few studies on the efficacy of antipsychotics on psychopathology and on their repercutions on substance abuse. Methods: All studies about pharmacological treatment of schizophrenic patients with substance abuse, included in Medline over the last ten years were analyzed. Results: Of the 17 studies reviewed, most were prospective with small samples (< 30 patients, 5 studies) or case reports (7 studies). Objetives were to assess the efficacy on schizophrenic symptoms and the effect of the treatment on substance use. Atypical antipsychotics were the most studied. These pharmacological agents mere effective at reducing symptoms and had few side effects. They also managed to reduce substance abuse in 66-75% of patients. Conclusions: In spite of underlyng methodological problems of these studies, the findings suggest that atypical antipsychatics could be the treatment of choice in these patients.
    Original languageEnglish
    Pages (from-to)124-130
    JournalActas Espanolas de Psiquiatria
    Issue number2
    Publication statusPublished - 1 Mar 2001


    • Atypical antipsychotics
    • Schizophrenia
    • Substance abuse
    • Treatment


    Dive into the research topics of 'Treatment of schizophrenia in subjects with substance use disorders'. Together they form a unique fingerprint.

    Cite this